• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Our Company
    • About Us
    • Compliance and Quality
    • Careers
  • Our People
    • Management
    • Board of Directors
    • Investors
  • Our Technology
    • The Sonata System
    • Indications and Safety
    • Instructions for Use
    • Request for Medical or Scientific Information
  • Our News
    • Press Releases
    • In the News
    • Publications
  • Contact Us

sydneywess

Shoneika’s Journey with Fibroids and the Sonata Treatment

March 25, 2025

Shoneika Jefferson, a professor and mother, struggled for years with painful fibroid symptoms, including heavy bleeding and severe cramping. In 2023, she turned to Dr. Monica Modi at Atrium Health, who recommended the Sonata treatment. After undergoing the procedure, Shoneika saw a major improvement

Gynesonics Announces New York Medicaid Coverage for CPT Code 58580, Transcervical Radio Frequency Ablation of Uterine Fibroids

December 17, 2024

Decision Expands Access to the Sonata® Treatment for Women Suffering from Uterine Fibroids, offering a Minimally Invasive Alternative to Hysterectomy or Myomectomy Redwood City, CA – December 17, 2024 – Gynesonics Inc., a medical device company focused on the development of minimally invasive

There is help for women with uterine fibroids

November 18, 2024

Greenville News shared that  Dr. Samy Iskandar, an obstetrician and gynecologist at Bon Secours OB-GYN in South Carolina, is now offering a groundbreaking treatment for uterine fibroids at Bon Secours St. Francis. This minimally invasive procedure uses an intrauterine ultrasound handpiece to locate

Hospital offers non-invasive procedure for removing fibroids

October 5, 2024

In a recent segment on WISH-TV, I-Team 8 highlighted a new fibroid removal procedure offering relief to women in Indiana. Ascension St. Vincent Carmel became the first hospital in the state to offer fibroid treatment without incisions. The segment featured interviews with local medical professionals

Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids

September 28, 2024

Revolutionizing Fibroid Treatment with Enhanced Precision, Control & Flexibility REDWOOD CITY, CA, September 26, 2024 – Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the launch of its new

Gynesonics® Reaches Milestone with 10,000th Patient Treatment with Sonata System

August 20, 2024

Cutting-edge incision-free solution advances standard of care for women with uterine fibroids REDWOOD CITY, CA, August 20, 2024 – Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine

Focus Atlanta with Dr. De from the Fibroid and Pelvic Wellness Center of Georgia

August 13, 2024

On the CBS Atlanta 69 segment, Focus Atlanta, host Keisha Lancelin interviewed Dr. De from the Fibroid and Pelvic Wellness Center of Georgia to discuss fibroids. Dr. De highlighted common fibroid symptoms and emphasized the importance of early treatment. She also informed viewers about the various

First-of-its-Kind Uterine Fibroid Treatment Comes to UConn Health

August 4, 2024

A new, less costly, less invasive, and less time-consuming option for treating uterine fibroids is now available to the women of Connecticut. NBC Connecticut features a segment on the Sonata Treatment with insights from Dr. Jessie Jones and Dr. Amanda Urich of UConn Health. Watch the news segment

  • Page 1
  • Page 2
  • Next Page »

Primary Sidebar

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information

© Copyright 2025 Gynesonics · All Rights Reserved · WS 05198 Rev. M

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information